dexmedetomidine has been researched along with Experimental Radiation Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Çınar, S; Karakaş, S; Mercantepe, T; Rakıcı, S; Saral, S; Şen, A; Topçu, A; Tümkaya, L; Yılmaz, A | 1 |
| Akdogan, A; Bahat, Z; Besir, A; Canyilmaz, E; Demirci, Y; Erturk, E; Kara, H; Kayir, S; Kutanis, D; Vanizor Kural, B | 1 |
2 other study(ies) available for dexmedetomidine and Experimental Radiation Injuries
| Article | Year |
|---|---|
Can Dexmedetomidine Be Effective in the Protection of Radiotherapy-Induced Brain Damage in the Rat?
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Avoidance Learning; Brain Injuries; Dexmedetomidine; Male; Neuroprotective Agents; Radiation Injuries, Experimental; Radiotherapy; Rats; Rats, Sprague-Dawley | 2021 |
Dexmedetomidine acts as an oxidative damage prophylactic in rats exposed to ionizing radiation.
Topics: Analgesics, Non-Narcotic; Animals; Antioxidants; Biomarkers; Catalase; Dexmedetomidine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Kidney; Liver; Lung; Male; Malondialdehyde; Oxidative Stress; Oxidoreductases; Prospective Studies; Radiation Injuries, Experimental; Radiation, Ionizing; Random Allocation; Rats; Rats, Sprague-Dawley; Serum Albumin; Serum Albumin, Human; Superoxide Dismutase; Thyroid Gland | 2016 |